The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

 
Web www.patentalert.com

< Imaging agents for early detection and monitoring of cardiovascular plaque

< Stimulating neutrophil function to treat inflammatory bowel disease

> Quinazolinones

> Treating neurological disorders using selective antagonists of persistent sodium current
~ 00269